Pfizer Q2 2026 revenue up 1%; raises 2026 guidance
Pfizer achieved operational revenue growth in Q2 2026 and raised its full-year 2026 revenue guidance, demonstrating continued business strength despite a reported diluted loss per share due to non-cash impairments.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day